Drug Trial Radar · NCT06108544
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
Last checked: Nov 19, 2026Latest source record: Nov 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,108
Actual
Start
Nov 6, 2023
Primary completion
Dec 6, 2024
Study completion Nov 7, 2025
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Oct 31, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque psoriasis. Participants will be assigned to one of the 3 study treatments (TAK-279, apremilast (an approved treatment), or a placebo). Participants will be in the study for up to 69 weeks.
Conditions
- Plaque Psoriasis
Interventions
TAK-279Drug
Specified drug on specified days.
PlaceboDrug
Specified drug on specified days.
ApremilastDrug
Specified drug on specified days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving a Static Physician's Global Assessment (sPGA) of Clear (0) or Almost Clear (1) With a ≥2-Point Decrease from Baseline at Week 16 Comparing TAK-279 Against PlaceboTime frame: Baseline, Week 16
- Percentage of Participants Achieving ≥75% Improvement from Baseline in Psoriasis Area and Severity Index (PASI) Score at Week 16 Comparing TAK-279 Against PlaceboTime frame: Baseline, Week 16
Locations
217 sites in 16 countries. Site status is shown where the registry gives one.
Total Dermatology
Birmingham, Alabama
Cahaba Dermatology Skin Health Center
Hoover, Alabama
Medical Dermatology Specialists
Phoenix, Arizona
Noble Clinical Research
Tucson, Arizona
Johnson Dermatology Clinic
Fort Smith, Arkansas
Burke Pharmaceutical Research
Hot Springs, Arkansas
Zenith Research, Inc.
Beverly Hills, California
UNISON Clinical Trials (Shahram Jacobs md inc.)
Encino, California
First OC Dermatology Research Inc.
Fountain Valley, California
Long Beach Research Institute, LLC
Long Beach, California
Metropolis Dermatology Downtown LA - Probity - PPDS
Los Angeles, California
Northridge Clinical Trials
Northridge, California
TCR Medical Corporation
San Diego, California
University Clinical Trials
San Diego, California
Dermatology Institute and Skin Care Center
Santa Monica, California
Revival Research Corporation - Florida - ClinEdge - PPDS
Doral, Florida
Florida Academic Centers Research
Miami, Florida
San Marcus Research Clinic Inc
Miami Lakes, Florida
FXM Research Miramar
Miramar, Florida
Lenus Research & Medical Group
Sweetwater, Florida
Advanced Clinical Research Institute (ACRI) - Florida
Tampa, Florida
Olympian Clinical Research - 6331 Memorial Hwy
Tampa, Florida
Divine Dermatology and Aesthetics, LLC
Atlanta, Georgia
Advanced Medical Research, PC
Atlanta, Georgia
Skin Care Physicians of Georgia
Macon, Georgia
NorthShore Medical Group Dermatology - Skokie
Skokie, Illinois
DS Research - 1005 E. Lewis & Clark Pkwy Indiana Location
Clarksville, Indiana
Skin Sciences, PLLC
Louisville, Kentucky
DS Research of Kentucky
Louisville, Kentucky
Dermatology & Advanced Aesthetics
Lake Charles, Louisiana
Lawrence J Green, MD LLC
Rockville, Maryland
Allcutis Research LLC
Beverly, Massachusetts
Beacon Clinical Research LLC
Brockton, Massachusetts
David Fivenson MD Dermatology PLLC
Ann Arbor, Michigan
University of Michigan Hospital - 1500 E Medical Center Dr
Ann Arbor, Michigan
Oakland Hills Dermatology - 3400 Auburn Rd
Auburn Hills, Michigan
Minnesota Clinical Study Center
Fridley, Minnesota
Skin Specialists PC
Omaha, Nebraska
Vivida Dermatology - Flamingo Rd - Probity - PPDS
Las Vegas, Nevada
ALLCUTIS Research, LLC.
Portsmouth, New Hampshire
Showing 40 of 217 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.